Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2022 Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2022 Earnings Call Transcript November 8, 2022

Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.17 EPS, expectations were $-0.89.

Operator: Welcome to the Revance Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following managements’ prepared remarks, we will hold a question-and-answer session. As a reminder, this call is...